Skip to main content

Neurofibromatosis News

Related terms: NF, Neurofibromatosis-1, Neurofibromatosis 2, NF1, Von Recklinghausen neurofibromatosis, NF2, Bilateral acoustic neurofibromatosis, Central bilateral acoustic NF

FDA Approves Koselugo (selumetinib) for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas

13 April 2020 – AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that the US Food and Drug Administration (FDA) has approved...

Ask a question

To post your own question to this support group, sign in or create an account.